Efficacy of nutritional counseling to improve liver enzyme and steatosis in patients with non-alcoholic fatty liver disease combined with hyperlipidemia taking antihyperlipidemic agent

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002890

Enrollment

Registered

2018-05-23

Start date

2018-03-01

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : In the case of the control group, only anti-hyperlipemia medication is taken. In the case of the experimental group, intensive nutritional counseling education in addition to the antihype

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 19 to 75 years 2. patients diagnosed as nonalcoholic fatty liver disease 3. ALT or ALT 40 or higher 4. Patients with hyperlipidemia requiring statin therapy

Exclusion criteria

Exclusion criteria: 1. Younger than 19, or older than 75 2. Patients with diabetes or HbA1c > 6.5 3. If triglycerides are over 500 mg / dL 4. decompensated liver cirrhosis 5. Significant alcohol intake 6. Medications that can cause fatty liver 7. hepatitis B or hepatitis C infection 8. hepatocellular carcinoma 9. decreased kidney function (GFR < 60) 10. history of ketoacidosis 11. pregnancy or lactation 12. Patients who did not agree with the study

Design outcomes

Primary

Measure	Time frame
Changes in ALT levels before and 12 months after treatment	—

Secondary

Measure	Time frame
Changes in AST levels before and 12 months after treatment;Changes in LDL levels before and 12 months after treatment;Changes in BMI before and 12 months after treatment;Changes in NAFLD fibrosis score before and 12 months after treatment	—

Countries

Korea, Republic of

Contacts

Public ContactJeong-Ju Yoo

Soon Chun Hyang University Hospital Bucheon

puby17@naver.com+82-32-625-5585

Outcome results